Healthy Aging Research
Open Access

Intermittent Fasting and Its Role in Promoting Healthy Aging and Metabolic Balance

Reza Iacopino^{* *}Correspondence: Reza Iacopino, Department of Global Health Research, University of Bergamo, Bergamo, Italy, Email:

Author info »

Description

Intermittent Fasting (IF) has emerged as a prominent dietary strategy with potential to promote healthy aging and metabolic balance. Characterized by alternating periods of eating and fasting, IF influences a wide array of physiological processes linked to longevity, cellular health, and chronic disease prevention. Unlike caloric restriction, which focuses on reducing daily caloric intake, IF manipulates the timing of food intake, making it more accessible for many people to adopt. Recent research has highlighted how IF affects genetic pathways, modulates metabolic regulators, and contributes to systemic homeostasis in older adults.

The fasting state also promotes the upregulation of SIRT1, a gene involved in DNA repair, mitochondrial biogenesis, and inflammation suppression. SIRT1 interacts with the transcriptional coactivator Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha (PGC-1α), enhancing mitochondrial function and energy metabolism. These adaptations have significant implications for aging populations, where mitochondrial dysfunction and systemic inflammation are commonly observed. The resulting metabolic shift during IF supports ketogenesis, a process where the body produces ketone bodies like β-hydroxybutyrate, which serve as efficient energy substrates for the brain and heart and act as signaling molecules that further promote longevity-associated pathways.

Cognitive health in older adults is another critical area where intermittent fasting may confer benefits. Studies in both animal models and human subjects suggest that intermittent fasting improves synaptic plasticity, neurogenesis, and cognitive performance. The production of Brain-Derived Neurotrophic Factor (BDNF), a protein crucial for learning and memory, is enhanced during fasting periods. This neuroprotective factor helps strengthen existing neurons and promote the growth of new ones in the hippocampus, an area of the brain responsible for memory formation. Moreover, ketone bodies generated during fasting provide neuroprotective effects by reducing oxidative stress and inflammation, both of which are implicated in neurodegenerative disorders such as Alzheimer's and Parkinson’s diseases.

Metabolic disorders, including insulin resistance, type 2 diabetes, and dyslipidemia, are common in aging populations and are key contributors to morbidity. Intermittent fasting has been shown to enhance insulin sensitivity, reduce fasting glucose levels, and improve lipid profiles. The improved insulin responsiveness is thought to be mediated through the activation of Forkhead Box O (FOXO) transcription factors and downregulation of inflammatory cytokines. In particular, FOXO3, a gene associated with human longevity, is activated during periods of nutrient scarcity and helps in the maintenance of metabolic equilibrium. These molecular adaptations reduce systemic inflammation, a condition often referred to as "inflammaging," which contributes to the pathogenesis of many age-related diseases.

Cardiovascular health, a major concern in elderly individuals, also appears to benefit from intermittent fasting. Animal and human studies have shown reductions in resting heart rate, blood pressure, triglycerides, and Low-Density Lipoprotein (LDL) cholesterol levels during IF regimens. The endothelial function is improved through increased nitric oxide availability, which promotes vasodilation and vascular health. Additionally, IF has been shown to reduce arterial stiffness, a marker of vascular aging, by mitigating oxidative stress and enhancing antioxidant defense systems.

Weight regulation is a significant challenge in older adults, especially given the decreased basal metabolic rate and physical activity levels associated with aging. Intermittent fasting promotes weight loss by creating an energy deficit, but more importantly, it appears to preferentially reduce visceral adiposity-fat deposits around the internal organs that are closely linked to metabolic diseases. Visceral fat is metabolically active and secretes pro-inflammatory adipokines that can exacerbate insulin resistance and cardiovascular disease. By targeting this fat depot, IF contributes not only to a healthier body composition but also to reduced systemic inflammation and improved metabolic outcomes. Beyond physical health, IF may influence circadian rhythm, which tends to deteriorate with age and contributes to sleep disturbances, metabolic dysfunction, and mood disorders. Time-restricted feeding, a form of intermittent fasting where food intake is limited to a certain number of hours per day, helps realign circadian clocks by synchronizing feeding-fasting cycles with the body’s internal rhythms. This entrainment enhances hormonal balance, glucose metabolism, and overall homeostasis.

Clinical trials in humans, though still limited in scale and duration, provide promising evidence that intermittent fasting can be a safe and effective strategy for older adults. A randomized controlled trial involving adults aged 60 and above demonstrated significant reductions in body weight, fasting insulin, and oxidative stress markers after 12 weeks of intermittent fasting. Importantly, participants reported improved well-being, better sleep quality, and enhanced energy levels, indicating that IF is not only biologically beneficial but also well-tolerated in older populations.

Despite its advantages, intermittent fasting may not be suitable for everyone, particularly frail elderly individuals, those with chronic illnesses, or people on medications that require consistent food intake. Careful monitoring and personalized guidance are essential when older adults adopt fasting regimens. Further research is also required to determine the long-term effects of IF, the optimal duration and frequency of fasting, and the mechanisms through which it interacts with other lifestyle factors such as exercise and dietary quality.

Conclusion

Intermittent fasting holds significant promise as a nonpharmacological intervention to promote healthy aging and metabolic balance. Through modulation of nutrient-sensing pathways, enhancement of mitochondrial function, promotion of neuroprotection, and reduction of systemic inflammation, IF addresses many of the core processes that underlie aging and age-related diseases. While more large-scale studies are needed to establish guidelines tailored for older adults, current evidence suggests that IF is a valuable tool in the broader framework of geriatric health and longevity.